Telik Inc (NASDAQ:TELK)

CAPS Rating: 2 out of 5

A biopharmaceutical company working to discover, develop and commercialize innovative small molecule drugs to treat diseases.

Recs

0
Player Avatar 0l0l (< 20) Submitted: 4/18/2007 2:30:27 AM : Outperform Start Price: $192.00 TELK Score: -92.54

Telcyta works.

Report this Post Reply

Featured Broker Partners


Advertisement